Establishment of Medicines Safety Program January 2017

The Australian Digital Health Agency is pleased to announce the establishment of a new Medicines Safety Program.

Good medicines management can help to reduce the likelihood of medication errors and hence patient harm. The Program is designed to improve the access and quality of medicines information through the use of digital health, enabling consumers and healthcare providers to make safe, informed decisions and achieve better health outcomes.

The Program’s Executive Sponsor is Dr Monica Trujillo, the Agency’s Executive General Manager Clinical and Consumer Engagement and Clinical Governance, and Chief Clinical Information Officer.  The Agency welcomes the Programme Co-Sponsors Dr Steve Hambleton and Mr Steven Renouf who will advocate the interests of clinicians and consumers, and Mr Neville Board representing the Australian Commission on Safety and Quality in Health Care (ACSQHC).  

The first Steering Group meeting took place in Sydney on Thursday 8 December 2016 with 27 members in attendance representing a range of healthcare peak bodies and consumer groups.  The group will meet quarterly.  A full list of Steering Group members is at the end of the Communique.    

The Program has four primary objectives:

  1. Undertake and validate an environment scan of all the current and planned digital activities that support access to safer medicines; identify opportunities for improved coordination, collaboration, and investment.
  2. Identify existing Agency projects that should be governed by the Medicines Safety Programme to ensure coordination and prioritisation based on the target outcomes, dependencies, and interdependencies.
  3. Identify new priority projects or activities, through consultation with the healthcare sector, which should be delivered directly by the Agency or through partnerships with other organisations. This will include the investigation of any short-term opportunities for improvement identified through the National Digital Health Strategy consultation, which should be included in the Agency work plan.
  4. Develop an evidence-based, sector-wide digital Medicines Safety Programme roadmap, including a benefits realisation plan to monitor progress of both adoption and outcomes.

In the short term, the group will engage with consumers and clinicians on enhancing medicines management use and capability in the My Health Record system.

Steering Group members

  • Australian Commission on Quality and Safety in Health Care 
  • Pharmacy Guild of Australia
  • The Pharmaceutical Society of Australia
  • The Society of Hospital Pharmacists Australia
  • Australian Private Hospitals Association
  • Australian Nursing and Midwifery Federation 
  • Pharmaceutical Benefits Branch (Commonwealth Department of Health)
  • Therapeutic Goods Administration
  • NPS MedicineWise
  • Australian Medical Association
  • Royal Australian College of General Practitioners
  • Royal Australasian College of Physicians
  • Medical Software Industry of Australia
  • Australian College of Rural and Remote Medicine 
  • Jurisdictional representatives
  • Aged and Community Services Australia 
  • Consumer Health Forum
  • Academic(s)



Media contact:

Alison Sweeney
Senior Communications and Media Officer
02 8298 2669 / 0414 187 350
[email protected]